Some classical inflammatory biomarkers, including CRP, SAA1, ORM1, and LBP, were determined to further confirm the notably lower inflammatory responses of IBD patients with overweight/obesity than those without overweight/obesity (Fig. 5E). This evidence concerns the gene CRP and inflammatory bowel disease.